AC Immune
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $939 | $1,306 | $990 | $1,137 |
Gross Profit | 939 | 1,306 | 990 | 1,137 |
EBITDA | -15,518 | -20,516 | -18,363 | -15,235 |
EBIT | -15,858 | -21,139 | -18,975 | -15,764 |
Net Income | -15,858 | -21,189 | -19,029 | -15,797 |
Net Change In Cash | 939 | 1,306 | 990 | 1,137 |
Free Cash Flow | -18,398 | -15,971 | -19,178 | 5,844 |
Cash | 27,741 | 25,722 | 19,960 | 36,275 |
Basic Shares | 99,112 | 100,631 | 100,408 | 100,858 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $27,309 | $14,801 | $3,935 | $944 |
Gross Profit | -35,261 | -39,805 | 3,935 | -62,282 |
EBITDA | -48,618 | -51,832 | -68,026 | -70,006 |
EBIT | -50,780 | -54,047 | -70,385 | -72,412 |
Net Income | -50,916 | -54,233 | -70,753 | -72,996 |
Net Change In Cash | 27,309 | 14,801 | 3,935 | 944 |
Free Cash Flow | 65,266 | -61,209 | -74,807 | -68,324 |
Cash | 36,275 | 78,494 | 31,586 | 82,216 |
Basic Shares | 99,692 | 84,694 | 83,554 | 74,951 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | -$0.16 |
2025-06-30 | -$0.21 |
2025-03-31 | -$0.19 |
